Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001799812-20-000002
Filing Date
2020-01-17
Accepted
2020-01-17 11:01:58
Documents
1
Effectiveness Date
2020-01-17
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5924
  Complete submission text file 0001799812-20-000002.txt   7108
Mailing Address C/O ADJUVANT CAPITAL, L.P. 445 5TH AVENUE, #20D NEW YORK NY 10016
Business Address C/O ADJUVANT CAPITAL, L.P. 445 5TH AVENUE, #20D NEW YORK NY 10016 917-334-0724
Adjuvant Global Health Technology Fund DE, L.P. (Filer) CIK: 0001799812 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-358359 | Film No.: 20532636